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In this study, a medical device made of surface microstructured bacterial cellulose was produced using 
cellulose‑producing acetic acid bacteria wild‑type strains in combination with guided assembly‑based 
biolithography. The medical device aims at interfering with the cell’s focal adhesion establishment 
and maturation around implantable devices placed in soft tissues by the symmetrical array on its 
surface. A total of 25 Komagataeibacter strains was evaluated over a three‑step selection. In the 
first step, the ability of strains to produce a suitable bacterial cellulose layer with high production 
yield was examined, then nine strains, with a uniform and smooth layer of bacterial cellulose, were 
cultured in a custom‑made silicone bioreactor and finally the characteristics of the symmetrical array 
of topographic features on the surface were analysed. Selected strains showed high inter and intra 
species variability in bacterial cellulose production. The devices obtained by K2G30, K1G4, DSM 
46590 (Komagataeibacter xylinus), K2A8 (Komagataeibacter sp.) and DSM  15973T (Komagataeibacter 
sucrofermentas) strains were pouched‑formed with hexagonal surface pattern required for reducing 
the formation of fibrotic tissue around devices, once they are implanted in soft tissues. Our findings 
revealed the effectiveness of the selected Komagataeibacter wild‑type strains in producing surface 
microstructured bacterial cellulose pouches for making biomedical devices.
The search for biopolymers with innovative attributes is a challenge for the biotechnological industry. In this 
frame, bacterial cellulose (BC) in the native and functionalized form has received extensive attention due to fea-
tures, such as high-water holding capacity, high light transparency, non-toxicity, purity and  biocompatibility1,2. 
Based on the structural and safety characteristics of BC and its derivates, this biopolymer has been proposed 
in several fields such as food, textile, pharmaceutical, biomedical, cosmetic, environmental and engineering 
 applications3–9. According to the United States Food and Drug Administration (FDA), BC is is “generally recog-
nized as safe” (GRAS)10,11. Recently, the European Food Safety Authority (EFSA) Scientific Panel on Biological 
Hazards (BIOHAZ) included the species Komagataeibacter sucrofermentans in the list of QPS-recommended 
biological agents, intentionally added to  food12. Previous studies highlighted the absence of BC cytotoxicity on 
mouse fibroblast cells and its suitability as the carrier of active medical and cosmetic  formulations13,14.
For instance, BC could be used as a vehicle for antibiotics or medicines, allowing their transfer to the wound. 
At the same time, it acts as a physical barrier against external  infections3,15. Moreover, BC is adaptable to the 
wound surface and provides an exudate absorption thus it is possible to use it as a matrix for the epithelialization 
of burns even of third-degree15,16. BC grafts might potentially reduce the rejection rates of transplanted corneas 
and improve the treatment of eye diseases (e.g., age-related macular degeneration) mainly due to the augmenting 
local neovascularization, diminishing side effects, and surgical recovery  intervals17. However, it is widely known 
that the human body recognizes the foreign material immediately after implantation, and it could trigger an 
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inflammatory response followed by a sequence of events that lead to the deposition of fibrotic  tissue18,19. Such 
an event is correlated with several health risks for patients, both during control interventions and after, when 
the functionality of the implanted device is  required20.
The intrinsic characteristics of BC, such as the non-toxic chemical composition, the purity, the high porosity, 
the bulk mechanical properties, and the matrix-like morphology, make it advantageous in biomedical applica-
tions to prevent the fibrotic adhesion, as documented by several  studies15,21–23. Indeed, it was previously reported 
that the adverse conditions for adhesion, between cells and BC, are established by an isotropic distribution of 
topographical features, which physically interfere with the establishment and maturation of focal  adhesion21,24. 
The micro-structuration of BC’s surface is possible using a Guided Assembly-Based Biolithography (GAB), which 
is a powerful replica molding methodology to transfer on-demand functional topographies to the surface of BC 
nanofiber textures. BC nanofibers are assembled in a three-dimensional network reproducing the hexagonal 
pattern imposed by the  mold20,24,25. Thus, the formation of the pattern on the surface of BC inhibits the initial 
biological  recognition22 avoiding the formation of fibrotic tissue around implantable devices placed in soft tissues.
Among BC producing organisms, acetic acid bacteria (AAB) of the Komagataeibacter genus comprise spe-
cies such as Komagataeibacter xylinus, K. hansenii and K. sucrofermentas with high production yield which are 
reported as native or functionalized biomaterial  pruducers1.
In the present work, 25 AAB wild-type strains belonging to the Komagataeibacter genus were evaluated for 
their suitability to synthesize a medical device made of surface microstructured BC in combination with GAB.
Due to high intraspecific variability within AAB in producing  BC26, 9 strains were selected based on BC 
production yield and shape. Selected strains were cultured inside the bioreactor and their characteristics of the 
symmetrical array on the surface were analysed. Promising outcomes have been obtained by 5 strains, which 
produced the required surface-microstructured BC. This study provides new evidence for the use of wild-type 
AAB strains as biological machineries for producing biomedical devices.
Results and discussion
Assessment of bacterial cellulose production by Komagataeibacter strains. The amount and 
shape of BC produced by AAB strains are presented in Table 1. AAB species considered for this study were K. 
xylinus, K. hansenii, and K. sucrofermentans, which are reported as the highest BC producers among the species 
of the Komagataeibacter  genus27–32. BC was produced by all the strains; however, a great variability was observed 
not only on the macroscopic structure of the native BC (Supplementary Fig. S1), but also in terms of weight. 
Table 1.  Weight of dried BC and shape of native BC produced by AAB strains used in this study and their 
isolation source. Values are given as mean ± standard deviation (n = 3). Different lowercase letters in the same 
column indicate significant differences (p < 0.05). Bold fonts refer to strains that were chosen for surface-
microstructured BC production. ND not detectable.
Strain Dried BC (g) Native BC in liquid cultivation Isolation source Species
K1A1826 0.0168n ± 0.0001 Uniform and smooth Liquid kombucha tea fraction Komagataeibacter sp.
K1G4 = UMCC 294731 0.2096a ± 0.0001 Uniform and smooth Liquid kombucha tea fraction K. xylinus
K1G2326 0.0629b ± 0.0001 Uniform and smooth Liquid kombucha tea fraction Komagataeibacter sp.
K2A826 0.0401e ± 0.0001 Uniform and smooth Liquid kombucha tea fraction Komagataeibacter sp.
K2A10 = UMCC  296526 0.0162n ± 0.0001 Uniform Liquid kombucha tea fraction Komagataeibacter sp.
K2A826 0.0293g ± 0.0002 Uniform and smooth Liquid kombucha tea fraction Komagataeibacter sp.
K2G826 0.0296g ± 0.0001 Uniform and smooth Liquid kombucha tea fraction Komagataeibacter sp.
K2G1026 0.0230l ± 0.0001 Uniform Liquid kombucha tea fraction Komagataeibacter sp.
K2G1426 0.0317f ± 0.0001 Uniform Liquid kombucha tea fraction Komagataeibacter sp.
K2G1526 0.0264i ± 0.0001 Uniform Liquid kombucha tea fraction Komagataeibacter sp.
K2G30 = UMCC 275633 0.0519d ± 0.0002 Uniform and smooth Pellicle kombucha tea fraction K. xylinus
K2G39 = UMCC 297026 0.0540c ± 0.0002 Uniform and smooth Liquid kombucha tea fraction Komagataeibacter sp.
K2G41 = UMCC  297126 0.0247k ± 0.0001 Uniform and smooth Liquid kombucha tea fraction Komagataeibacter sp.
K2G44 = UMCC  297226 0.0132p ± 0.0001 Uniform Pellicle kombucha tea fraction Komagataeibacter sp.
DSM 15973T 34 0.0164n ± 0.0001 Uniform and smooth Black cherry K. sucrofermentas
DSM  200435 0.0294g ± 0.0001 Uniform Unknown source K. xylinus
DSM  232535 0.0276h ± 0.0006 Uniform Unknown source K. xylinus
DSM 46590 0.0255j ± 0.0001 Uniform and smooth Unknown source K. xylinus
DSM 46591 0.0194m ± 0.0002 Uniform and smooth Unknown source K. xylinus
DSM  4660236 0.0064q ± 0.0001 Fragmented Vinegar K. xylinus
DSM  4660336 0.0127p ± 0.0001 Fragmented Unknown source K. xylinus
DSM 4660437 0.0155° ± 0.0005 Uniform and smooth Unknown source K. xylinus
DSM  4660536 0.0041r ± 0.0004 Fragmented Vinegar brew K. xylinus
DSM  6513T 37 0.0047r ± 0.0002 Fragmented Mountain ash berries K. xylinus
DSM  5602T 38 ND Fragmented Vinegar K. hansenii
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Some strains produced a uniform and homogenous BC layer, smooth on the surface, which was easily removed 
from the culture broth without damaging its shape. Whereas other strains produced a fragmented BC layer with 
a heterogenous and compact macrostructure. Once removed from the culture broth the cellulosic matrix has 
lost its original shape.
Considering this study aimed to synthesize a medical device made of surface-microstructured BC, 9 strains 
producing uniform and smooth BC layers of different weights (Supplementary Fig. S2) were selected for further 
investigation. Among them, 5 strains were isolated from Kombucha tea, one from black cherry and 3 from 
unknown isolation sources (Table 1).
The variability in BC production has been previously observed for strains of the genus Komagataeibacter 
and within strains of the same species (e.g., K. xylinus). In the Komagataeibacter genus, differences in cellulose 
synthase (CS) complex have been correlated to a different ability in BC  production39. The main reason for this 
difference is due to the number of bcs operons, which generally span from 1 to 3 in members of the Komaga-
taeibacter  genus39,40. However in K. xylinus species two strains were described to possess a fourth copy of bcsAB 
 gene33,41. We previously obtained and analysed K2G30 and K1G4 genomes. The K2G30 genome possesses three 
bcs operons and a fourth copy of bcsAB gene, that encodes the catalytic core of CS. Whereas K1G4 analysis 
revealed the presence of the two bcs operon types structurally completed and a third copy of bcsAB  gene31,33. 
These features can explain the high amount of BC produced by these two strains.
Other factors that contribute to strain variability in BC production are, the isolation source and handling of 
culture. Most of the strains of this study originated from food matrices, especially Kombucha tea, which is con-
sidered a selective source for the recovery of BC producing  AAB21, while others were originally collected from 
sugared and acidic products. The laboratory culturing of strains also affects the stability of phenotypic traits. This 
phenomenon is already observed for AAB when they are continuously cultivated and preserved by short-time 
preservation methods, which increase the formation of high rate of spontaneous  mutants42,43.
Production of surface‑structured bacterial cellulose with guided assembly‑based biolithogra‑
phy. Cultures derived from the nine selected strains were tested in the polydimethylsiloxane (PDMS) biore-
actor, using the same conditions as during the previous tests (Hestrin–Schramm44 (HS) broth; 5% v/v inoculum; 
incubation at 28 °C for 7 days). Outcomes confirmed the great variability in native BC weight (Fig. 1a) (Sup-
plementary Table S1) and characteristics. Some strains differed from the others to produce non-optimal BC 
pouches. K1G4, K2G30 and K2G39 strains produced the highest amount of BC, but the formed pouch did not 
have optimal attributes. Also, the visual analysis of transparency and thickness of the pouches varied among 
strains (Data not shown). To assess the suitability of the strains for the purpose of this study, it has been hypoth-
Figure 1.  Weight of native BC produced by screened strains. BC weight was obtained after incubation at 28 °C 
for 7 (a) and 3, 4, 5 (b) days inside bioreactor. Values are given as mean ± standard deviation (n = 3).
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esized to reduce the incubation time to 3, 4, and 5 days for the highest producers (K2G30, K2G39, and K1G4) 
(Fig. 1b). Results showed that the optimal production required 3 days of cultivation. The yield of BC production 
and its characteristics are also influenced by the type of vessel in which the microbial strains grow. Considering 
AAB strictly aerobic organisms, in the static cultivation regime, BC is formed at specific sites of the air surface 
of  liquids45. Therefore, production in terms of yield is dependent on the ratio between the surface exposed to air 
and the volume (S/V ratio) of the vessel, in which bacteria grow.
The bioreactor used in this study allows the transfer of oxygen, which is a key factor in the production of BC 
by the Komagataeibacter sp. The constant diffusion of oxygen is permitted by the non-polar nature of the  PDMS46. 
Indeed, the lower the polarity of a material is, the higher is the permeability to the oxygen, as reported for other 
materials, such as film composites with whey protein isolate and  pectin47,48. Therefore, a higher BC yield was 
reached for most of the culture strains due to the bigger gas–liquid interface (Table 2). Moreover, oxygen inside 
the bioreactor was further increased by the high permeability of  PDMS49,50.
Considering the cultivation method used in this study, the gas–liquid interface area of the 100 mL flask was 
approximately 9.42  cm2, whereas in the case of the bioreactor it was nearly 120  cm2, of which just 9.5  cm2 of the 
free interface. Consequently, by approximating the geometric structure of the 100 mL flask to a truncated cone 
with diameters of 6.60 cm and 6.00 cm, and by approximating the structure of the bioreactor to a parallelepiped, 
the S/ V ratios were 0.60  cm2/cm3 and 1.75  cm2/cm3, respectively.
Even though the higher BC production occurred inside the PDMS bioreactors, the size of the pouches pro-
duced by strain DSM 46604 was smaller than that required, and it collapsed, not standing at the level at which the 
bacterial culture had been inoculated. Once the strain was grown inside the PDMS bioreactor, the structure of 
the pocket composed by BC, to support its sidewalls, has nothing but the BC itself. The collapse of the structure 
could be correlated to the slowness of the BC pace synthesis by the microbial strain, which leads to the absence 
of a unique and packed biofilm BC formation inside the bioreactor. Therefore, the DSM 46604 strain did not 
produce satisfactory results from a structural point of view.
As already mentioned, through a continuous exchange of oxygen, bacteria can produce BC also within the 
walls of the bioreactor (Fig. 2), even though more slowly than the upper part, which is directly in contact with the 
air. Therefore, a thick layer of BC was observed for almost all strains at the open liquid–air interface at the end of 
incubation time. A sort of closed cap, sealing the top of the surface-microstructured BC pouch was formed. That 
cap was easily removed from the rest of the BC and the devices assumed the pouch-shape, without any damage 
to the BC. Most of tested strains formed the removable cap with two exceptions. In surface-microstructured BC 
produced by DSM 46591 and DSM 46604, the thicker layer was not visible and, consequently, not possible to 
remove without damaging the rest of the BC.
Our outcomes highlight that the use of defined AAB strains is a versatile strategy that allows obtaining cos-
tumed devices, modulating the growth conditions. Moreover, for some strains a reduction in cultivation time 
was proved, which is a further milestone for using AAB in industry. Based on these results, K2G30 and the K1G4 
(3 days of cultivation), and K2A8, DSM  15973T, and DSM 46590 (7 days of cultivation) are candidate strains for 
surface-microstructured BC production assisted by GAB.
Characterization of surface‑structured bacterial cellulose with guided assembly‑based bio‑
lithography. Since the surface micropattern designed by Hylomorph AG has characteristic dimensions in 
the sub-micron range (1–10 µm), brightfield microscopy (BF) and scanning electron microscopy (SEM) were 
used to investigate the presence of the surface micropattern on the pouches. All the 5 candidate strains (K2G30, 
K1G4, K2A8, DSM  15973T and DSM 46590) showed the hexagonal pattern on the surface using BF (Fig. 3a). 
In parallel, SEM analysis with high magnification was performed to observe the surface of the matrix and to 
confirm the fibrous network of BC (Fig. 3b,c). Moreover, to visualize how bacterial cells are dispersed into the 
BC matrix (Fig. 3d), a K2A8 sample, as representative of the pool of strains, was differently treated for SEM 
experiment, by turning the BC pouch inside out and reducing the washing steps. Results are consistent with the 
literature describing AAB of Komagataeibacter genus as short rods with an average width of 0.65 µm (ranging 
Table 2.  Dried BC yield (g/L) produced after incubation at 28 °C for 7 days inside flasks and bioreactor. 
Values are given as mean ± standard deviation (n = 3). Different lowercase letters in the same column indicate 
significant differences (p < 0.05).
Strain
Flask (30 mL) Bioreactor (55 mL)
Yield (g/L) ± st dev (g/L) Yield (g/L) ± st dev (g/L)
K1G4 6.9867a ± 0.0033 3.7020bc ± 0.4153
K1G23 2.0967b ± 0.0033 2.8348cd ± 0.2950
K2G39 1.8011c ± 0.0069 3.8764b ± 0.4344
K2G30 1.7311d ± 0.0051 4.8939a ± 0.2734
K2A8 1.3367e ± 0.0033 2.5028d ± 0.5575
DSM  15973T 0.5456f ± 0.0019 0.8077e ± 0.0387
DSM 46604 0.5156g ± 0.0168 0.4907e ± 0.0621
DSM 46590 0.8511h ± 0.0019 0.8721e ± 0.2112
DSM 46591 0.6478i ± 0.0051 0.4992e ± 0.0705
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from 0.5 to 0.8 µm) and an average length of 2 µm (ranging from 1.0 to 3.00 μm), occurring singly, in pairs or 
in  chain51.
Conclusions
In this work, 25 Komagataeibacter strains were tested for producing a BC device suitable for biomedical purposes. 
The medical device was manufactured in the form of a pouch, synthesized by AAB at the liquid–air interface, 
after a period of incubation inside a PDMS bioreactor. Among studied strains, K2G30, K1G4, K2A8, DSM 
 15973T and DSM 46590 produced optimal surface-microstructured BC and they were designated as candidate 
strains for the purpose of this study. Although a further research step is required to evaluate the biocompatibility, 
the durability of the device and the reduction of fibrotic tissue, results of this study open new horizons toward 
applying wild-type AAB strains in the biomedical field.
Materials and methods
Materials. HS broth was prepared following the recipe: D-glucose 2% w/v, Yeast extract 1% w/v, Polypeptone 
0.5% w/v, Disodium phosphate anhydrous  (NaHPO4) 0.27% w/v, Citric acid 0.115% w/v)44. Whereas the 105 
broth was prepared according to DSMZ instructions: D-glucose 10% w/v, calcium carbonate  (CaCO3) 2% w/v, 
Yeast extract 1% w/v. Sterilization was conducted in an autoclave at 121 °C for 20 min.
Bacterial strains and cultivation conditions. AAB strains used in this study were supplied by UMCC 
(Unimore Microbial Culture Collection, Italy) and DSMZ (Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH, Braunschweig, Germany) culture collections, respectively (Table 1). All the strains were 
handled by UMCC culture collection, according to the standard procedures of the Microbial Resource Research 
Infrastructure—Italian Joint Research Unit (MIRRI-IT)52.
DSMZ strains were revitalized according to manufacturer instructions, using 105 broth and UMCC strains on 
HS broth. After revitalization, a pre-inoculum was performed on 5 mL HS broth. Then an aliquot of inoculum 
(5% v/v) was transferred in a 100 mL Erlenmeyer flask containing 30 mL HS broth. Incubation was performed 
at 28 ˚C for 7 days, under static conditions.
Qualitative and quantitative tests of BC. BC production was qualitatively estimated following the 
method proposed by Navarro et al.,  199953. Pellicle was collected from the broth culture after 7 days of incuba-
tion at 28 °C, treated with 4 mL of 5% NaOH and boiled for 2 h. BC production has been confirmed when the 
pellet did not dissolve after boiling. K. xylinus K2G30 was used as a positive control.
Figure 2.  Formation of BC layer inside the PDMS bioreactor.
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Estimation of BC yield was carried out following the method proposed by Hwang et al.  199954. Briefly, native 
BC from culture broth was collected and washed with distilled water four times with a time-lapse of 15 min and 
additional washing with 1 M NaOH. Washed BC films were kept at 90 °C for 30 min inside the solution of NaOH 
1 M. Finally, BC was rinsed using distilled water four times and then dried at 25 °C until a constant weight was 
reached. The weighting of the dried BC film was performed using an analytical balance (Gibertini E42S, Milan 
Italy). The yield of BC was expressed as grams of dried BC per liter (g/L).
Growth of AAB in 3D bioreactors. 3D bioreactors manufactured in PDMS were used as vessels for 
assessing the development of surface microstructured BC by Komagataeibacter genus strains. Cultivation in the 
bioreactor was carried out with 55 mL of HS broth and 5% v/v inoculum. Bioreactors were covered with sterile 
gauze on the top and incubated at 28 °C for 7 days. Then, each sample was washed using at first distilled water, 
then a solution of NaOH 1 M and rinsed with distilled water several times. The last washing in distilled water 
was conducted in shaking conditions. BC production within the bioreactor was evaluated by the formation of a 
homogeneous film with a cap at an open liquid–air interface. The sealing of the pouch was removed aseptically 
and avoiding the damaging of the BC pouch-shaped device. The yield of BC produced was controlled as previ-
ously described and expressed in grams of dried BC per liter (g/L).
Microscopy. The surface microstructure of BC pouches was examined using a field emission scanning elec-
tron microscope (NovaNano SEM 450, FEI, USA). Samples were cut (5 × 5  mm2) and mounted on a stainless-
steel stub with double-sided tape. The analysis was performed in a low vacuum mode (80 kPa) with an accelera-
tion voltage of 10  kV55. The surface microstructure pattern of the films was obtained through a BF microscopy 
Eclipse Ts2 inverted microscope (Nikon, Tokyo, Japan).
Statistics analysis. The statistical analysis of the data was performed through analysis of variance 
(ANOVA) using multcompView package implemented in R v 4.0.456. The experiment was performed in 3 rep-
licates. The differences between means were evaluated by Tukey HSD test (p < 0.05). The data were expressed as 
the mean ± standard deviation (SD).
Figure 3.  K2A8 strain as representative of the pool of strains. (a) Micro-pattern characterization. Hexagonal 
pattern of the surface-microstructured BC manufactured using biolithography. Hexagonal pattern-formation 
was observed by BF microscopy at high magnification ×20 using native BC. (b) SEM image of surface-
microstructured BC. (c) SEM image of microstructured BC fibrous network. (d) SEM image of K2A8 present 
among microstructured BC fibrous network.
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Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information file).
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